Indrapr.Medical

72
Buy
  • Market Cap: Small Cap
  • Industry: Hospital
  • ISIN: INE681B01017
  • NSEID: INDRAMEDCO
  • BSEID: 532150
INR
488.80
0.35 (0.07%)
BSENSE

Dec 16

BSE+NSE Vol: 2.06 lacs

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationProfit and Loss Results
Results Snapshot
Figures in Cr
Standalone - Profit And Loss Results
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
Mar'20
Profit And Loss Analysis Highlights
stock-summary

Net Sales

YoY Growth in year ended Mar 2025 is 8.97% vs 13.29% in Mar 2024

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in year ended Mar 2025 is 26.33% vs 28.31% in Mar 2024

stock-summary

Interest

YoY Growth in year ended Mar 2025 is 54.43% vs -5.14% in Mar 2024

stock-summary

Profit After Tax

YoY Growth in year ended Mar 2025 is 29.87% vs 43.89% in Mar 2024

Compare Profit and Loss Results of Indrapr.Medical
Markets Mojo
Figures in Cr
standalone - Profit And Loss Results
Markets Mojo
Markets Mojo
Change(INR)
Change(%)
No of Months
12
12
Operating Income
1,356.00
913.00
443.00
48.52%
Less :Inter divisional transfers
0.00
0.00
0.00
0%
Less: Excise
0.00
0.00
0.00
0%
Net Sales
1,356.00
913.00
443.00
48.52%
Expenditure (Ex Depriciation)
Stock Adjustments
0.00
0.00
0.00
0%
Raw Materials Consumed
0.00
0.00
0.00
0%
Power & Fuel Cost
27.00
16.00
11.00
68.75%
Employee Cost
277.00
143.00
134.00
93.71%
Operating Expenses
254.00
477.00
-223.00
-46.75%
General and Administration Expenses
-1.00
-1.00
0.00
0.00%
Selling and Distribution Expenses
85.00
5.00
80.00
1,600.00%
Cost of Software developments
0.00
0.00
0.00
0%
Miscellaneous Expenses
59.00
6.00
53.00
883.33%
Expenses Capitalised
0.00
0.00
0.00
0%
Total Expenditure
1,112.00
763.00
349.00
45.74%
Operating Profit (PBDIT) excl Other Income
244.00
149.00
95.00
63.76%
Other Income
22.00
32.00
-10.00
-31.25%
Operating Profit (PBDIT)
266.00
182.00
84.00
46.15%
Interest
6.00
30.00
-24.00
-80.00%
Profit before Depriciation and Tax
260.00
152.00
108.00
71.05%
Depreciation
44.00
43.00
1.00
2.33%
Profit Before Taxation & Exceptional Items
216.00
109.00
107.00
98.17%
Exceptional Income / Expenses
0.00
0.00
0.00
0%
Profit Before Tax
216.00
109.00
107.00
98.17%
Provision for Tax
55.00
25.00
30.00
120.00%
Profit After Tax
160.00
83.00
77.00
92.77%
Extraordinary Items
0.00
0.00
0.00
0%
Adj to Profit After Tax
0.00
0.00
0.00
0%
Profit Balance B/F
355.00
213.00
142.00
66.67%
Profit Available for appropriations
516.00
297.00
219.00
73.74%
Appropriations
516.00
297.00
219.00
73.74%
Equity Dividend (%)
45%
45%
0.00
Earnings Per Share
17.56
5.42
12.14
223.99%
Profit And Loss - Net Sales
Net Sales 1,356.36 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is 8.97% vs 13.29% in Mar 2024

Profit And Loss - Operating Profit (PBDIT)
Operating Profit (PBDIT) 244.27 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is 26.33% vs 28.31% in Mar 2024

Profit And Loss - Interest
Interest 6.27 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is 54.43% vs -5.14% in Mar 2024

Profit And Loss - Profit After Tax
Profit After Tax 160.99 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is 29.87% vs 43.89% in Mar 2024